Article
How I treat AML incorporating the updated classifications and guidelines.
Blood - 8 Jun 2023
El Chaer Firas, Hourigan Christopher S, Zeidan Amer M
Abstract excerpt
The European LeukemiaNet recently revised both the clinical (2022) and measurable residual disease testing (2021) guidelines for acute myeloid leukemia (AML). The updated World Health Organization and International Consensus Classification for myeloid neoplasms were also published in 2022. Together, these documents update the classification, risk stratification, prognostication, monitoring recommendations, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
